Pharmabiz27m
HealthPlix gets HIPAA certification, reinforcing its efforts in patient data privacy and security
HealthPlix gets HIPAA certification, reinforcing its efforts in patient data privacy and security: Our Bureau, Bengaluru Tuesday, October 15, 2024, 15:30 Hrs [IST] HealthPlix Tech ...
Pharmabiz42m
C-CAMP with ICARS to support innovative solutions to address the challenge of AMR across the One Health domain
C-CAMP with ICARS to support innovative solutions to address the challenge of AMR across the One Health domain: Our Bureau, Bengaluru Tuesday, October 15, 2024, 15:15 Hrs [IST] Th ...
Pharmabiz57m
Lundbeck to buy clinical-stage biopharma company, Longboard Pharmaceuticals for USD 2.6 billion
Lundbeck to buy clinical-stage biopharma company, Longboard Pharmaceuticals for USD 2.6 billion: Valby, Denmark Tuesday, October 15, 2024, 15:00 Hrs [IST] H. Lundbeck A/S (Lundbec ...
Pharmabiz1h
Dizal gets China NMPA breakthrough therapy designation for sunvozertinib to treat NSCLC with EGFR exon 20 insertion mutations
Dizal gets China NMPA breakthrough therapy designation for sunvozertinib to treat NSCLC with EGFR exon 20 insertion mutations: Shanghai, China Tuesday, October 15, 2024, 14:30 Hrs ...
Pharmabiz1h
Exelixis, Merck enter clinical development collaboration to evaluate zanzalintinib in combo with Keytruda in HNSCC and in combo with Welireg in RCC
Alameda, California Tuesday, October 15, 2024, 14:00 Hrs [IST] ...
Pharmabiz2h
Lupin introduces generic Pred Forte in United States
Global pharma major Lupin Limited (Lupin) announced the launch of the first generic version of Pred Forte (prednisolone acetate) ophthalmic suspension USP, 1% in the United States. Being the first ...
Pharmabiz2h
US FDA approves UCB’s 320 mg single-injection device presentations of Bimzelx
US FDA approves UCB’s 320 mg single-injection device presentations of Bimzelx: Brussels, Belgium Tuesday, October 15, 2024, 13:00 Hrs [IST] UCB, a global biopharmaceutical compa ...
Pharmabiz3h
USV introduces OnArni for management of heart failure
Our Bureau, Mumbai Tuesday, October 15, 2024, 12:45 Hrs [IST] USV Pvt. Ltd. has introduced OnArni, a fixed dose combination ...
Pharmabiz3h
Majority of children with SMA treated with Roche’s Evrysdi are able to sit, stand and walk independently, two-year data demonstrate
Majority of children with SMA treated with Roche’s Evrysdi are able to sit, stand and walk independently, two-year data demonstrate ...
Pharmabiz5h
GSK announces positive phase III results from ANCHOR trials for depemokimab in chronic rhinosinusitis with nasal polyps
GSK announces positive phase III results from ANCHOR trials for depemokimab in chronic rhinosinusitis with nasal polyps: London, UK Tuesday, October 15, 2024, 10:00 Hrs [IST] GSK ...
Pharmabiz7h
NPPA approves 50% increase in ceiling prices of 11 formulations
NPPA approves 50% increase in ceiling prices of 11 formulations: Our Bureau, New Delhi Tuesday, October 15, 2024, 08:15 Hrs [IST] The National Pharmaceutical Pricing Authority (NP ...
Pharmabiz7h
Kerala branch of IPGA to host national annual conference of IPGA in Kochi on December 7
Kerala branch of IPGA to host national annual conference of IPGA in Kochi on December 7: Peethaambaran Kunnathoor, Chennai Tuesday, October 15, 2024, 08:00 Hrs [IST] In academic p ...